(SCI) Service International - Ratings and Ratios
Funeral Services, Cemetery Property, Cremation, Merchandise, Pre-Arranged Plans
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.66% |
| Yield on Cost 5y | 2.88% |
| Yield CAGR 5y | 11.37% |
| Payout Consistency | 80.7% |
| Payout Ratio | 34.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.3% |
| Value at Risk 5%th | 32.5% |
| Relative Tail Risk | -11.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.18 |
| Alpha | -11.67 |
| CAGR/Max DD | 0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.420 |
| Beta | 0.266 |
| Beta Downside | 0.163 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.97% |
| Mean DD | 8.55% |
| Median DD | 8.23% |
Description: SCI Service International October 31, 2025
Service Corporation International (SCI) operates the United States’ and Canada’s largest network of death-care providers, delivering funeral-home, cremation, and cemetery services under brands such as Dignity Memorial and Neptune Society. Its offerings span facility rentals, embalming, cremation, memorial merchandise, and interment rights (e.g., lawn crypts, mausoleum spaces), covering the full value chain from service execution to ancillary products.
In FY 2023 SCI generated approximately $5.5 billion in revenue, with an adjusted EBITDA margin near 12 % and same-store sales growth of roughly 3 % year-over-year. Key sector drivers include the aging U.S. population-U.S. Census projections show the 65-plus cohort will exceed 20 % of the population by 2030-and inflationary pressure on funeral-home pricing, which has historically allowed providers to pass cost increases to consumers without significant demand erosion. Cemetery occupancy rates remain high (≈ 85 % of developed lots), supporting stable cash flows even as cremation adoption rises.
For a deeper quantitative dive into SCI’s valuation metrics and scenario analysis, the ValueRay platform offers a useful toolkit.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (534.6m TTM) > 0 and > 6% of Revenue (6% = 257.4m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -0.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.75% (prev -8.53%; Δ 0.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 994.0m > Net Income 534.6m (YES >=105%, WARN >=100%) |
| Net Debt (4.79b) to EBITDA (1.24b) ratio: 3.87 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (143.2m) change vs 12m ago -2.05% (target <= -2.0% for YES) |
| Gross Margin 26.44% (prev 25.84%; Δ 0.59pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.99% (prev 23.84%; Δ 0.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.81 (EBITDA TTM 1.24b / Interest Expense TTM 254.5m) >= 6 (WARN >= 3) |
Altman Z'' 0.36
| (A) -0.02 = (Total Current Assets 419.7m - Total Current Liabilities 752.2m) / Total Assets 18.36b |
| (B) 0.02 = Retained Earnings (Balance) 440.1m / Total Assets 18.36b |
| (C) 0.05 = EBIT TTM 970.5m / Avg Total Assets 17.88b |
| (D) 0.03 = Book Value of Equity 586.1m / Total Liabilities 16.79b |
| Total Rating: 0.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.33
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.93% |
| 3. FCF Margin 14.42% |
| 4. Debt/Equity 3.21 |
| 5. Debt/Ebitda 3.87 |
| 6. ROIC - WACC (= 5.72)% |
| 7. RoE 33.12% |
| 8. Rev. Trend 32.54% |
| 9. EPS Trend -25.27% |
What is the price of SCI shares?
Over the past week, the price has changed by -0.05%, over one month by +1.04%, over three months by -3.29% and over the past year by -1.12%.
Is SCI a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.4 | 21.8% |
| Analysts Target Price | 95.4 | 21.8% |
| ValueRay Target Price | 80.2 | 2.4% |
SCI Fundamental Data Overview December 21, 2025
P/E Trailing = 21.0755
P/E Forward = 18.2815
P/S = 2.5545
P/B = 6.9917
P/EG = 1.5243
Beta = 0.986
Revenue TTM = 4.29b USD
EBIT TTM = 970.5m USD
EBITDA TTM = 1.24b USD
Long Term Debt = 4.96b USD (from longTermDebt, last quarter)
Short Term Debt = 67.3m USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.79b USD (from netDebt column, last quarter)
Enterprise Value = 15.75b USD (10.96b + Debt 5.03b - CCE 241.3m)
Interest Coverage Ratio = 3.81 (Ebit TTM 970.5m / Interest Expense TTM 254.5m)
FCF Yield = 3.93% (FCF TTM 618.9m / Enterprise Value 15.75b)
FCF Margin = 14.42% (FCF TTM 618.9m / Revenue TTM 4.29b)
Net Margin = 12.46% (Net Income TTM 534.6m / Revenue TTM 4.29b)
Gross Margin = 26.44% ((Revenue TTM 4.29b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 25.48%)
Tobins Q-Ratio = 0.86 (Enterprise Value 15.75b / Total Assets 18.36b)
Interest Expense / Debt = 1.31% (Interest Expense 65.7m / Debt 5.03b)
Taxrate = 26.94% (43.3m / 160.9m)
NOPAT = 709.0m (EBIT 970.5m * (1 - 26.94%))
Current Ratio = 0.56 (Total Current Assets 419.7m / Total Current Liabilities 752.2m)
Debt / Equity = 3.21 (Debt 5.03b / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = 3.87 (Net Debt 4.79b / EBITDA 1.24b)
Debt / FCF = 7.74 (Net Debt 4.79b / FCF TTM 618.9m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.91% (Net Income 534.6m / Total Assets 18.36b)
RoE = 33.12% (Net Income TTM 534.6m / Total Stockholder Equity 1.61b)
RoCE = 14.76% (EBIT 970.5m / Capital Employed (Equity 1.61b + L.T.Debt 4.96b))
RoIC = 10.82% (NOPAT 709.0m / Invested Capital 6.55b)
WACC = 5.10% (E(10.96b)/V(15.99b) * Re(7.0%) + D(5.03b)/V(15.99b) * Rd(1.31%) * (1-Tc(0.27)))
Discount Rate = 7.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.15%
[DCF Debug] Terminal Value 79.32% ; FCFE base≈606.3m ; Y1≈652.6m ; Y5≈801.9m
Fair Price DCF = 99.87 (DCF Value 14.00b / Shares Outstanding 140.2m; 5y FCF grow 8.57% → 3.0% )
EPS Correlation: -25.27 | EPS CAGR: -7.60% | SUE: 0.83 | # QB: 0
Revenue Correlation: 32.54 | Revenue CAGR: 0.38% | SUE: 1.38 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.04 | Chg30d=-0.006 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=4.24 | Chg30d=+0.024 | Revisions Net=+2 | Growth EPS=+10.2% | Growth Revenue=+3.5%
Additional Sources for SCI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle